Is divalproex (valproate semisodium) the same as valproate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Divalproex and Valproate: Essentially the Same Active Drug

Divalproex sodium (also called divalproex or valproate semisodium) is chemically a stable compound of sodium valproate and valproic acid in a 1:1 molar ratio, but once absorbed, it converts to the same active substance as valproate—the valproate ion. 1 They are the same medication in terms of their active form in your body.

Chemical Relationship

Divalproex sodium is formed during partial neutralization of valproic acid with sodium hydroxide, creating a coordination compound. 1 Regardless of whether you take valproic acid, sodium valproate, or divalproex sodium, the absorbed and active substance circulating in your bloodstream is the valproate ion. 2

Clinical Interchangeability

Guidelines treat divalproex sodium and sodium valproate as equivalent medications with identical dosing recommendations:

  • For migraine prevention: divalproex sodium 500-1,500 mg/day OR sodium valproate 800-1,500 mg/day 3, 4, 3
  • For bipolar disorder: both are first-line preventive agents at equivalent doses 1
  • For epilepsy: both are indicated for complex partial seizures and absence seizures 1

The FDA label confirms bioequivalence between divalproex and valproic acid. 1, 2

Practical Differences

While therapeutically equivalent, there are formulation differences:

Gastrointestinal tolerability: Divalproex has an enteric coating that may reduce GI side effects compared to immediate-release valproic acid. Studies show 14.7% vs 28.7% GI side effects respectively, with fewer discontinuations due to adverse events (4.0% vs 12.7%). 5 However, this advantage is due to the delayed-release formulation, not the chemical compound itself.

Absorption characteristics: Divalproex has a longer time to maximum concentration (Tmax) due to its gastro-resistant coating, but achieves the same total bioavailability. 2

Prescribing Considerations

When switching between formulations at equivalent doses, expect the same therapeutic effect. One study showed patients required higher doses of valproic acid to achieve similar blood levels as divalproex, 6 though this likely reflects formulation differences rather than true pharmacological distinctions.

The key point: divalproex and valproate refer to the same active medication—the valproate ion—just in different salt forms or formulations. Use the terms interchangeably when discussing efficacy, but specify the formulation when addressing tolerability or dosing schedules.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.